In NSCLC, aberrant activation of NRF2 not only enhances oxidative stress resistance and therapeutic tolerance, but also modulates NOTCH1 signaling, influencing apoptotic responses following radiation exposure. Here, NOTCH1 is linked to non-small cell lung carcinoma.